Vinegar Co-ingestion in Type 2 Diabetes

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status

Completed

Conditions

Type 2 Diabetes Mellitus

Treatments

Dietary Supplement: vinegar co-ingestion
Dietary Supplement: placebo co-ingestion

Study type

Interventional

Funder types

Other

Identifiers

NCT01279317
MEC 10-3-035

Details and patient eligibility

About

The main objective of this study is to assess the acute effect of co-ingested vinegar on postprandial plasma glucose levels in type 2 diabetes patients.

Full description

Plasma glucose and insulin concentrations are assessed over the 2 hr period following ingestion of carbohydrate-rich beverage with or without added vinegar.

Enrollment

12 patients

Sex

Male

Ages

40 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • male type 2 diabetes
  • overweight or obese
  • 40-70 yrs

Exclusion criteria

  • incident cardiovascular events during last year
  • peptic ulcer, duodenal ulcer, oesophageal reflux
  • antacids, H2 receptor blocker, proton pump inhibitors, NSAIDS, prokinetic agents

Trial design

12 participants in 2 patient groups, including a placebo group

vinegar co-ingestion
Experimental group
Description:
25 ml vinegar is added to glucose containing beverage
Treatment:
Dietary Supplement: vinegar co-ingestion
Placebo co-ingestion
Placebo Comparator group
Description:
25 ml vinegar is substituted by 25 ml water
Treatment:
Dietary Supplement: placebo co-ingestion

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems